Detailing Translational Development & Clinical Dose Escalation of JK06: A 5T4-Directed Biparatopic ADC
- Detailing clinical dose escalation activity of biparatopic ADC JK06 across efficacy, safety and PK data
- Contrasting emerging JK06 clinical profile versus anticipated results from the preclinical characterisation
- Explaining the potential of quadrivalent biparatopic ADCs to deliver differentiated clinical performance versus classical ADC design